Clinical trial
Side Effects After Direct-acting Antiviral Treatment in Patients With Chronic Hepatitis C. The EFINO-C Study.
NCT03346941 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Side Effects After Direct-acting Antiviral Treatment in Patients With Chronic Hepatitis C. The EFINO-C Study.
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2016
- Completion date
- October 31, 2017
- Enrollment
- 95 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic hepatitis c